QuidelOrtho on Monday announced that its subsidiary, Quidel, will invest funding totaling $750,000 and support over the next three years in American Heart Association (AHA) initiatives to promote cardiovascular and brain health, prevent heart disease and stroke, and support research.
As part of the collaboration, Quidel will invest the funding and give support for campaigns and initiatives led by the AHA's San Diego division.
"As we remain dedicated to addressing unmet needs in diseases, our top priority continues to be to elevate attention to heart disease," Douglas Bryant, chairman and CEO of QuidelOrtho, said in a statement.